Development of in vitro biocompatibility assays for surgical material

Clinical Orthopaedics and Related Research

Volumn 326, Issue , 1996, Pages 259-269

  Charissoux, J L ^a,e   Najid, A ^b,c   Cook Moreau, J ^d   Setton, D ^a   Rigaud, M ^d  

^a Hôpital Universitaire   (France)

^b Institut Analgesia   (France)

^c ZA de l'Islon   (France)

^d UNIVERSITY OF LIMOGES   (France)

^e DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; CARBON 14; CHROMIC ACID; HYDROXYICOSATETRAENOIC ACID; OPSONIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2; ZYMOSAN;

ALLERGIC REACTION; ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; BIOASSAY; BIOCOMPATIBILITY; CONTROLLED STUDY; INFLAMMATION; MACROPHAGE ACTIVATION; METAL IMPLANTATION; MOUSE; NONHUMAN; OPSONIZATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0029986541     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199605000-00033     Document Type: Article

References (42)

1. Anderson JM, Miller KM: Biomaterial biocompatibility and the macrophage. Biomaterials 5:5-10, 1984.
2. Bisgaard H, Kristensen J, Sondergaard J: The effect of leukotriene C4 and D4 2 on cutaneous blood flow in humans. Prostaglandins 23:797-801, 1982.
3. Bonta IL, Parnham MJ: Prostaglandins and chronic inflammation. Biochem Pharmacol 27:1611-1623, 1978.
4. Collier JP, Surprenant VA, Jensen RE, Mayor M, Surprenant HP: Corrosion between the components of modular femoral hip prostheses. J Bone Joint Surg 746:511-517, 1992.
5. Denizot Y, Najid A, Rigaud M: Incorporation of arachidonic acid in a human cancer gastric tumor cell line (HGT) at various of cell proliferation. Cancer Lett 68:199-205, 1993.
6. Dimitru A, Dy M, Thomson N, Hamburger J: Macrophage cytotoxicity in human immune response against a skin allograft. J Immunol 114: 195-199, 1974.
7. Dobbs HS, Minski MJ: Metal ion release after total hip replacement. Biomaterials 1:193-198, 1980.
8. Doran A, Rushton N, Law FC: The carcinogenic risk of orthopaedic metals: Further results of an in vitro study. J Bone Joint Surg 74B:(S2 abstract) 227, 1992.
9. Estensen RD, White JG, Holmes B: Specific degranulation of human polymorphonuclear leukocytes. Nature 248:347-348, 1974.
10. Evans EM, Freeman MAR, Miller AJ, Vernon Roberts B: Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total hip replacement. J Bone Joint Surg 566:626-642, 1974.
11. Fergusson AB, Akahoshi Y, Laing PG, Hodge ES: Characteristics of trace ions released from embedded metal implants in the rabbit. J Bone Joint Surg 44A:323-336, 1962.
12. Fergusson AB, Laing PG, Hodge ES: The ionization of metal implants in living tissues. J Bone Joint Surg 42A:77-90, 1960.
13. Ferreira SH, Vane JR: New aspects of the mode of action of non steroidal anti inflammatory drugs. Ann Rev Pharmacol 14:57-73, 1974.
14. Ford Hutchinson AW, Rackham A: Leukotrienes as mediators of skin inflammation. Prostaglandins 29:689-701, 1985.
15. Halpin DS: An unusual reaction in muscle in association with a vitallium plate: A report of possible metal hypersensitivity. J Bone Joint Surg 57B: 451-453, 1975.
16. Haynes DR, Rogers SD, Hay S, Pearcy MJ, Howie DW: The differences in toxicity and release of bone resorbing mediators induced by titanium and cobalt-chromium-alloy wear particles. J Bone Joint Surg 75A:825-834, 1993.
17. Horowitz SM, Doty SB, Lane JM, Burstein AH: Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg 75A:802-813, 1993.
18. Humes JL, Bonney RJ, Pelus L, et al: Macrophages synthesize and release prostaglandins in response to inflammatory stimuli. Nature 269:149-151, 1977.
19. Jacobs JJ, Skipor AK, Black J, Urban RM, Galante JO: Release and excretion of metal in patients who have a total hip replacement component made of titanium-base alloy. J Bone Joint Surg 73A: 1475-1486, 1991.
20. Johnson M, Carey F, McMillan RM: Alternative pathways of arachidonate metabolism: Prostaglandins, thromboxane and leukotrienes. Essays Biochem 19:40-141, 1983.
21. Jones DA, Lucas HK, O'Driscoll M, Price Ch G, Wibberley B: Cobalt toxicity after Mc Kee hip arthroplasty. J Bone Joint Surg 576:289-296, 1975.
22. Klickstein LB, Shapleigh C, Goetzl EJ: Lipoxy-genation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondylarthritis. J Clin Invest 66:1166-1170, 1980.
23. Koshihara Y, Nagasaki I, Murota SI: Production of slow reacting substance in rat granulomatous inflammation. Biochem Pharmacol 30:1781-1784, 1981.
24. Langlais F, Postel M, Berry GP, Le Carpentier Y, Weill BJ: L/intolérance aux débris d'usure des prothèses. Int Orthop 4:145-152, 1980.
25. Laugier P, Foussereau J: Les dermites allergiques a distance provoquées par le matériel d'ostéosynthèse. Gaz Med Fr 73:3409-3418, 1966
26. Lemaire G, Petit JF, Millon G: Culture de Macrophages in Culture de Cellules Animales: Méthodologies, Applications. In Adolphe M, Barlovatz Meimen G (eds). Paris, Ed Inserm. 301-312, 1988.
27. Lewis RA, Austen KF: Mediation of local homeostasis and inflammation by leukotrienes and other mast cell dependent compounds. Nature 293: 103-108, 1981.
28. Leynadier F, Langlais F, Kinderman A, et al: Prothèses métalliques et hypersensibilité aux métaux. Rev Fr Allergol 23:137-141, 1983.
29. Mc Millan RM, Spruce KE, Crawley GC, Walker ER, Foster SJ: Preclinical pharmacology of ICI D 2138: A potent orally-active non-redox inhibitor of 5-lipoxygenase. Br J Pharmacol 107:1042-1047, 1992.
30. Murray DW, Rushton N: Macrophages stimulate bone resorption when they phagocytose particles. J Bone Joint Surg 726:988-992, 1990.
31. Najid A, Simon A, Cook J, et al: Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differenciated HL 60 leukemic cells. FEBS Lett 299: 213-217, 1992.
32. Ohlin A, Johnell O, Lerner UH: The pathogenesis of loosening of total hip arthroplasties: The production of factors by periprosthetic tissues that stimulate in vitro bone resorption. Clin Orthop 253:287-296, 1990.
33. Postel M, Langlais F: L'usure des prothèses totales de hanche en stellite. Rev Chir Orthop 63(Suppl 2):84-94, 1977.
34. Rabinovitch Chable H, Durand J, Gualde N, Rigaud M: Metabolism of polyunsaturated fatty acids by mouse peritoneal macrophages: The lipoxygenase metabolic pathway. Agents Actions 11:580-583, 1981.
35. Rostoker G, Robin J, Binet O, Paupe J: Dermatoses par allergie et intolérance aux corps étrangers metalliques à usage médical. Rev Fr Allergol 26: 135-140, 1986.
36. Rostoker G, Robin J, Binet O, et al: Dermatis due to orthopaedic implants: A review of the literature and report of three cases. J Bone Joint Surg 69A: 1408-1412, 1987.
37. Safina AF, Korolenko TA, Mynkina GI, Dushkin MI, Krasnoselskaya GA: Liver and serum lysosomal enzymes activity during zymosan induced inflammation in mice. Agents Actions 38(Suppl): 370-375, 1992.
38. Sinibaldi K, Rosen H, Liu Si-Kwan, De Angelis M: Tumors associated with metallic implants in animals. Clin Orthop 118:257-266, 1976.
39. Swanson SAV, Freeman MAR, Heath JC: Laboratory tests on total joint replacement prostheses. J Bone Joint Surg 556:759-773, 1973.
40. Ward JJ, Thornbury DD, Lemons JE, Dunham WK: Metal induced sarcoma: A case report and literature review. Clin Orthop 252:299-306, 1990.
41. Wedmore CV, Williams TJ: Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289:646-650, 1981.
42. Woodman JL, Black J, Nunamaker DM: Release of cobalt and nickel from a new total finger joint prosthesis made of vitallium. J Biomed Mater Res 17: 655-668, 1983.